
Ex-Valeant CEO Michael Pearson is suing his former company over its failure to deliver three million shares he claims he …

The US Senate Aging Committee has announced the issuing of a subpoena to the outgoing CEO of Valeant Pharmaceuticals, Michael …

Valeant (NYSE:VRX) has announced that it has begun the search for a new CEO, confirming that Michael Pearson is to …

Valeant’s tough month continued yesterday, with a US congressional committee pressuring the company to explain why it has not produced …

This could prove a make-or-break year for Valeant.The specialist drug company begins 2016 with a reputation damaged by allegations of …

